What TEAM Actually Changes for Ortho and Spine Hospitals
On January 1, CMS placed 741 hospitals under mandatory 30-day episode accountability through the Transforming Episode Accountability Model, known as TEAM. The program covers five surgical categories, including joint replacement, hip fracture, and spine fusion, which means most ortho and spine service lines are now operating under a different financial model than they were just a year ago.
The structure is straightforward. CMS sets a target price for each episode, and hospitals that stay below that number keep the difference, while those that exceed it are responsible for the overage. Readmissions, ER visits, complications, and post-acute utilization during the 30-day window all directly impact that number. A single avoidable event can erase the margin from multiple clean cases.
This is not a theoretical model. The predecessor program, CJR, already demonstrated measurable savings, and TEAM extends that same framework into additional service lines, including spine. In October 2027, the model expands nationwide and extends accountability to 90 days, which means nearly every hospital will be operating under episode-based risk in the near future.
The shift is not subtle. It changes what hospitals need to manage after discharge.
The Post-Discharge Gap
Most hospitals follow a similar recovery protocol today. A call at day seven. A follow-up visit around six weeks. Between those two touchpoints, there is little to no visibility into how the patient is actually recovering at home.
That is the window where problems develop.
Pain that stops improving. Range of motion that stalls. Patients who quietly stop following their home program. Early signs of complications that go unnoticed. By the time these issues surface at the six-week visit, the financial impact has already occurred.
Under TEAM, this gap is no longer just a clinical limitation. It is directly tied to reimbursement.
Why the Current Model Falls Short
The major spine and ortho device companies are not built to solve this problem. Their role has historically ended at discharge, with a focus on the procedure itself rather than what happens after.
That model worked when post-discharge outcomes were absorbed by Medicare.
It does not work when hospitals carry the risk.
The question hospitals now need to answer is simple. How do we see what is happening after the patient leaves the building.
What Changes With Daily Visibility
Recupe addresses the gap by extending visibility into the home environment. Patients leave with a wearable sensor and an app, while the clinical team monitors recovery through a dashboard that tracks range of motion, pain trends, adherence, and activity on a daily basis.
The difference is timing.
When recovery trends in the wrong direction, the team can act early with a call, a therapy adjustment, or a clinic visit before the issue escalates into a readmission. Instead of reacting weeks later, the care team stays connected throughout the episode window.
The outcomes reflect that approach. Patients reach functional range of motion faster, intervention rates such as MUA decrease, pain scores improve, and engagement remains significantly higher than traditional follow-up methods. These are not abstract metrics, they directly influence how the episode is priced.
Alignment at the Surgeon Level
CMS built alignment into the model through 42 CFR 510.500, which allows hospitals to share up to 50 percent of savings with participating surgeons. This creates a direct link between recovery outcomes and financial performance across the care team.
When post-discharge performance improves, the benefit is shared.
That changes how quickly programs are adopted and how consistently they are used.
The Timeline Is Shorter Than It Looks
Hospitals that implement a post-discharge platform now have the advantage of refining workflows while the accountability window is still 30 days. By the time the model expands to 90 days nationwide, those systems will already be established.
Hospitals that wait will be building infrastructure under active financial pressure.
Where This Leaves the Market
The shift is not about introducing a new treatment. It is about closing a gap that has always existed but was never tied to financial outcomes.
Orthotics, implants, and procedures still matter.
But under TEAM, visibility during recovery matters just as much.
To see the full Recupe fit for your TEAM service lines, contact Michael Droege at mdroege@fairwindsmedical.com
Ready to accelerate your commercialization?
Fair Winds Medical helps medtech companies navigate from concept to market. Let's talk.
Schedule a Consultation →